, Singapore
360 views
Photo from MOH

MOH adjusts MediShield life claim limit for cancer drug services

The claim limit increased to $3,6000 per calendar year.

The MediShield Life claim limit for cancer drug services will increase from  $1,200 per calendar year to $3,600 per calendar year starting 1 April, the Ministry of Health (MOH) announced. 

According to the MOH, the increase in the claim limit will ensure  “the affordability of cancer drug treatments and sustainability of insurance premiums in the long term.”

Explaining the adjustment, MOH said it received feedback that the claim limit may not “be adequate for some patients who require more frequent tests to monitor disease progression or who require more supportive care drugs to manage their side effects.”

“There is no change to the MediSave withdrawal limit of $600 per calendar year. Patients who made cancer drug services claims in 2023 will be able to make additional MediShield Life claims from 1 April 2023, up to the new limit,” the MOH said.

The health ministry likewise adjusted the Integrated Shield Plan coverage to cover only treatments on the Cancer Drug List upon policy purchase or renewal. The adjustment will also take effect on 1 April.

Follow the link for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare